Share Price and Basic Stock Data
Last Updated: January 15, 2025, 12:06 am
PEG Ratio | 8.98 |
---|
Competitors of Uravi T and Wedge Lamps Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Varroc Engineering Ltd | 6,615 Cr. | 433 | 717/399 | 38.8 | 105 | 0.00 % | 17.5 % | 41.9 % | 1.00 |
Uravi T and Wedge Lamps Ltd | 450 Cr. | 412 | 670/254 | 268 | 35.1 | 0.00 % | 10.2 % | 8.83 % | 10.0 |
Lumax Industries Ltd | 2,390 Cr. | 2,562 | 3,045/1,960 | 18.1 | 745 | 1.37 % | 17.2 % | 17.6 % | 10.0 |
Fiem Industries Ltd | 3,785 Cr. | 1,440 | 1,790/1,074 | 19.7 | 354 | 1.39 % | 26.6 % | 20.1 % | 10.0 |
Industry Average | 3,310.00 Cr | 1,211.75 | 86.15 | 309.78 | 0.69% | 17.88% | 22.11% | 7.75 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Sales | 8.85 | 9.24 | 8.46 | 7.36 | 8.76 | 10.62 | 11.53 | 11.08 |
Expenses | 7.64 | 7.44 | 7.13 | 6.90 | 7.30 | 8.88 | 9.97 | 9.41 |
Operating Profit | 1.21 | 1.80 | 1.33 | 0.46 | 1.46 | 1.74 | 1.56 | 1.67 |
OPM % | 13.67% | 19.48% | 15.72% | 6.25% | 16.67% | 16.38% | 13.53% | 15.07% |
Other Income | 0.06 | 0.18 | 0.29 | 0.19 | 0.18 | 0.19 | 0.06 | 0.26 |
Interest | 0.30 | 0.70 | 0.58 | 0.47 | 0.54 | 0.56 | 0.60 | 0.57 |
Depreciation | 0.53 | 0.56 | 0.55 | 0.55 | 0.57 | 0.58 | 0.60 | 0.62 |
Profit before tax | 0.44 | 0.72 | 0.49 | -0.37 | 0.53 | 0.79 | 0.42 | 0.74 |
Tax % | -22.73% | 50.00% | 32.65% | -2.70% | -16.98% | 27.85% | 9.52% | 25.68% |
Net Profit | 0.54 | 0.36 | 0.33 | -0.36 | 0.62 | 0.58 | 0.38 | 0.55 |
EPS in Rs | 0.49 | 0.33 | 0.30 | -0.33 | 0.56 | 0.53 | 0.35 | 0.50 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Uravi T and Wedge Lamps Ltd based on the most recent figures (Mar 2024) and their trends compared to the previous period:
- For Sales, as of Mar 2024, the value is ₹11.08 Cr.. The value appears to be declining and may need further review. It has decreased from 11.53 Cr. (Dec 2023) to ₹11.08 Cr., marking a decrease of 0.45 Cr..
- For Expenses, as of Mar 2024, the value is ₹9.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.97 Cr. (Dec 2023) to ₹9.41 Cr., marking a decrease of 0.56 Cr..
- For Operating Profit, as of Mar 2024, the value is ₹1.67 Cr.. The value appears strong and on an upward trend. It has increased from 1.56 Cr. (Dec 2023) to ₹1.67 Cr., marking an increase of 0.11 Cr..
- For OPM %, as of Mar 2024, the value is 15.07%. The value appears strong and on an upward trend. It has increased from 13.53% (Dec 2023) to 15.07%, marking an increase of 1.54%.
- For Other Income, as of Mar 2024, the value is ₹0.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.06 Cr. (Dec 2023) to ₹0.26 Cr., marking an increase of 0.20 Cr..
- For Interest, as of Mar 2024, the value is ₹0.57 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.60 Cr. (Dec 2023) to ₹0.57 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Mar 2024, the value is ₹0.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.60 Cr. (Dec 2023) to ₹0.62 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2024, the value is ₹0.74 Cr.. The value appears strong and on an upward trend. It has increased from 0.42 Cr. (Dec 2023) to ₹0.74 Cr., marking an increase of 0.32 Cr..
- For Tax %, as of Mar 2024, the value is 25.68%. The value appears to be increasing, which may not be favorable. It has increased from 9.52% (Dec 2023) to 25.68%, marking an increase of 16.16%.
- For Net Profit, as of Mar 2024, the value is ₹0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.38 Cr. (Dec 2023) to ₹0.55 Cr., marking an increase of 0.17 Cr..
- For EPS in Rs, as of Mar 2024, the value is 0.50. The value appears strong and on an upward trend. It has increased from 0.35 (Dec 2023) to 0.50, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2011 | Mar 2012 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 10.19 | 16.11 | 29.44 | 28.94 | 33.82 | 35.22 | 36.14 | 27.80 | 31.34 | 33.90 | 41.99 | 44.32 |
Expenses | 8.29 | 12.89 | 24.56 | 24.32 | 27.29 | 28.24 | 30.73 | 25.49 | 26.23 | 29.02 | 35.57 | 37.75 |
Operating Profit | 1.90 | 3.22 | 4.88 | 4.62 | 6.53 | 6.98 | 5.41 | 2.31 | 5.11 | 4.88 | 6.42 | 6.57 |
OPM % | 18.65% | 19.99% | 16.58% | 15.96% | 19.31% | 19.82% | 14.97% | 8.31% | 16.31% | 14.40% | 15.29% | 14.82% |
Other Income | 0.00 | 0.00 | 0.15 | 0.15 | 0.13 | 0.27 | 0.34 | 0.60 | 0.28 | 0.71 | 0.69 | 0.71 |
Interest | 0.74 | 1.68 | 2.07 | 1.75 | 1.66 | 1.55 | 1.89 | 1.87 | 2.18 | 2.12 | 2.26 | 2.29 |
Depreciation | 0.20 | 0.47 | 1.40 | 1.43 | 1.46 | 1.65 | 1.87 | 2.35 | 2.09 | 2.19 | 2.36 | 2.40 |
Profit before tax | 0.96 | 1.07 | 1.56 | 1.59 | 3.54 | 4.05 | 1.99 | -1.31 | 1.12 | 1.28 | 2.49 | 2.59 |
Tax % | 27.08% | 32.71% | 39.74% | 33.96% | 22.03% | 29.14% | 18.59% | -24.43% | 33.93% | 32.03% | 14.46% | |
Net Profit | 0.69 | 0.72 | 0.94 | 1.05 | 2.76 | 2.87 | 1.62 | -0.99 | 0.73 | 0.87 | 2.13 | 1.96 |
EPS in Rs | 6.90 | 0.72 | 0.94 | 1.05 | 2.51 | 2.61 | 1.47 | -0.90 | 0.66 | 0.79 | 1.94 | 1.79 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
Year | 2011-2012 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 4.35% | 11.70% | 162.86% | 3.99% | -43.55% | -161.11% | 173.74% | 19.18% | 144.83% |
Change in YoY Net Profit Growth (%) | 0.00% | 7.35% | 151.16% | -158.87% | -47.54% | -117.56% | 334.85% | -154.56% | 125.65% |
Uravi T and Wedge Lamps Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2011-2012 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | 15% |
TTM: | 27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -6% |
3 Years: | 61% |
TTM: | 44% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 52% |
3 Years: | 87% |
1 Year: | 33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | 6% |
Last Year: | 9% |
Last Updated: Unknown
Balance Sheet
Last Updated: January 13, 2025, 2:35 pm
Month | Mar 2011 | Mar 2012 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.50 | 5.00 | 5.00 | 5.00 | 5.50 | 5.50 | 5.50 | 5.50 | 5.50 | 11.00 | 11.00 | 11.00 |
Reserves | 0.84 | 1.57 | 4.73 | 5.78 | 12.84 | 15.71 | 17.34 | 16.39 | 17.13 | 12.43 | 14.52 | 27.64 |
Borrowings | 9.97 | 12.62 | 16.67 | 14.55 | 13.67 | 16.66 | 20.41 | 22.91 | 22.90 | 22.85 | 24.57 | 25.04 |
Other Liabilities | 1.45 | 1.86 | 6.73 | 4.00 | 4.44 | 4.33 | 4.15 | 3.01 | 3.72 | 5.27 | 5.43 | 5.60 |
Total Liabilities | 12.76 | 21.05 | 33.13 | 29.33 | 36.45 | 42.20 | 47.40 | 47.81 | 49.25 | 51.55 | 55.52 | 69.28 |
Fixed Assets | 6.63 | 10.80 | 14.78 | 14.27 | 13.47 | 16.63 | 16.78 | 15.62 | 15.49 | 14.93 | 14.72 | 14.21 |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.23 | 0.00 | 2.95 | 2.54 | 2.62 |
Investments | 0.00 | 0.00 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.67 | 0.92 | 0.01 | 0.01 | 10.83 |
Other Assets | 6.13 | 10.25 | 18.29 | 15.00 | 22.92 | 25.51 | 30.51 | 31.29 | 32.84 | 33.66 | 38.25 | 41.62 |
Total Assets | 12.76 | 21.05 | 33.13 | 29.33 | 36.45 | 42.20 | 47.40 | 47.81 | 49.25 | 51.55 | 55.52 | 69.28 |
Below is a detailed analysis of the balance sheet data for Uravi T and Wedge Lamps Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹27.64 Cr.. The value appears strong and on an upward trend. It has increased from 14.52 Cr. (Mar 2024) to ₹27.64 Cr., marking an increase of 13.12 Cr..
- For Borrowings, as of Sep 2024, the value is ₹25.04 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 24.57 Cr. (Mar 2024) to ₹25.04 Cr., marking an increase of 0.47 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹5.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.43 Cr. (Mar 2024) to ₹5.60 Cr., marking an increase of 0.17 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹69.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55.52 Cr. (Mar 2024) to ₹69.28 Cr., marking an increase of 13.76 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹14.21 Cr.. The value appears to be declining and may need further review. It has decreased from 14.72 Cr. (Mar 2024) to ₹14.21 Cr., marking a decrease of 0.51 Cr..
- For CWIP, as of Sep 2024, the value is ₹2.62 Cr.. The value appears strong and on an upward trend. It has increased from 2.54 Cr. (Mar 2024) to ₹2.62 Cr., marking an increase of 0.08 Cr..
- For Investments, as of Sep 2024, the value is ₹10.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2024) to ₹10.83 Cr., marking an increase of 10.82 Cr..
- For Other Assets, as of Sep 2024, the value is ₹41.62 Cr.. The value appears strong and on an upward trend. It has increased from 38.25 Cr. (Mar 2024) to ₹41.62 Cr., marking an increase of 3.37 Cr..
- For Total Assets, as of Sep 2024, the value is ₹69.28 Cr.. The value appears strong and on an upward trend. It has increased from 55.52 Cr. (Mar 2024) to ₹69.28 Cr., marking an increase of 13.76 Cr..
Notably, the Reserves (₹27.64 Cr.) exceed the Borrowings (25.04 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
No data available for this post.
Free Cash Flow
Month | Mar 2011 | Mar 2012 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -8.07 | -9.40 | -11.79 | -9.93 | -7.14 | -9.68 | -15.00 | -20.60 | -17.79 | -17.97 | -18.15 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2011 | Mar 2012 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 138.62 | 123.48 | 115.92 | 102.79 | 101.13 | 108.51 | 131.70 | 160.97 | 142.79 | 119.84 | 118.57 |
Inventory Days | 182.90 | 152.26 | 159.35 | 228.96 | 233.80 | 286.16 | 358.76 | 366.65 | 339.45 | ||
Days Payable | 112.35 | 57.75 | 60.91 | 28.74 | 32.53 | 37.52 | 44.98 | 76.63 | 70.13 | ||
Cash Conversion Cycle | 138.62 | 123.48 | 186.47 | 197.31 | 199.56 | 308.72 | 332.97 | 409.60 | 456.57 | 409.86 | 387.89 |
Working Capital Days | 166.92 | 184.88 | 172.71 | 142.90 | 145.91 | 197.73 | 239.36 | 343.73 | 320.86 | 301.15 | 272.95 |
ROCE % | 18.03% | 12.91% | 18.14% | 16.03% | 9.57% | 1.27% | 8.37% | 7.43% | 9.86% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 1.94 | 0.79 | 1.33 | -1.80 | 2.95 |
Diluted EPS (Rs.) | 1.94 | 0.79 | 1.33 | -1.80 | 2.95 |
Cash EPS (Rs.) | 4.09 | 2.78 | 5.14 | 2.48 | 6.36 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 23.20 | 21.30 | 41.14 | 39.80 | 41.52 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 23.20 | 21.30 | 41.14 | 39.80 | 41.52 |
Revenue From Operations / Share (Rs.) | 38.17 | 30.82 | 57.02 | 50.54 | 65.74 |
PBDIT / Share (Rs.) | 6.46 | 5.02 | 9.70 | 5.22 | 10.39 |
PBIT / Share (Rs.) | 4.31 | 3.03 | 5.89 | 0.94 | 6.98 |
PBT / Share (Rs.) | 2.26 | 1.16 | 2.03 | -2.38 | 3.62 |
Net Profit / Share (Rs.) | 1.94 | 0.78 | 1.33 | -1.80 | 2.95 |
PBDIT Margin (%) | 16.92 | 16.29 | 17.00 | 10.34 | 15.80 |
PBIT Margin (%) | 11.30 | 9.83 | 10.32 | 1.86 | 10.62 |
PBT Margin (%) | 5.92 | 3.76 | 3.55 | -4.71 | 5.49 |
Net Profit Margin (%) | 5.08 | 2.55 | 2.33 | -3.56 | 4.48 |
Return on Networth / Equity (%) | 8.36 | 3.70 | 3.23 | -4.52 | 7.10 |
Return on Capital Employeed (%) | 15.88 | 11.74 | 11.74 | 2.01 | 14.92 |
Return On Assets (%) | 3.84 | 1.68 | 1.48 | -2.07 | 3.42 |
Long Term Debt / Equity (X) | 0.13 | 0.15 | 0.16 | 0.13 | 0.07 |
Total Debt / Equity (X) | 0.94 | 0.96 | 1.00 | 1.04 | 0.86 |
Asset Turnover Ratio (%) | 0.78 | 0.67 | 0.64 | 0.58 | 0.80 |
Current Ratio (X) | 1.48 | 1.44 | 1.47 | 1.39 | 1.40 |
Quick Ratio (X) | 0.76 | 0.76 | 0.83 | 0.84 | 0.90 |
Inventory Turnover Ratio (X) | 1.32 | 1.17 | 1.19 | 1.37 | 1.85 |
Interest Coverage Ratio (X) | 3.15 | 2.68 | 2.51 | 1.57 | 3.09 |
Interest Coverage Ratio (Post Tax) (X) | 1.95 | 1.42 | 1.35 | 0.45 | 1.88 |
Enterprise Value (Cr.) | 360.05 | 144.83 | 89.60 | 100.52 | 71.75 |
EV / Net Operating Revenue (X) | 8.57 | 4.27 | 2.86 | 3.62 | 1.98 |
EV / EBITDA (X) | 50.66 | 26.22 | 16.80 | 34.98 | 12.55 |
MarketCap / Net Operating Revenue (X) | 8.04 | 3.64 | 2.19 | 2.89 | 1.52 |
Price / BV (X) | 13.23 | 5.28 | 3.04 | 3.67 | 2.41 |
Price / Net Operating Revenue (X) | 8.04 | 3.64 | 2.19 | 2.89 | 1.52 |
EarningsYield | 0.01 | 0.01 | 0.01 | -0.01 | 0.02 |
After reviewing the key financial ratios for Uravi T and Wedge Lamps Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 0.79 (Mar 23) to 1.94, marking an increase of 1.15.
- For Diluted EPS (Rs.), as of Mar 24, the value is 1.94. This value is below the healthy minimum of 5. It has increased from 0.79 (Mar 23) to 1.94, marking an increase of 1.15.
- For Cash EPS (Rs.), as of Mar 24, the value is 4.09. This value is within the healthy range. It has increased from 2.78 (Mar 23) to 4.09, marking an increase of 1.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 23.20. It has increased from 21.30 (Mar 23) to 23.20, marking an increase of 1.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 23.20. It has increased from 21.30 (Mar 23) to 23.20, marking an increase of 1.90.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 38.17. It has increased from 30.82 (Mar 23) to 38.17, marking an increase of 7.35.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 6.46. This value is within the healthy range. It has increased from 5.02 (Mar 23) to 6.46, marking an increase of 1.44.
- For PBIT / Share (Rs.), as of Mar 24, the value is 4.31. This value is within the healthy range. It has increased from 3.03 (Mar 23) to 4.31, marking an increase of 1.28.
- For PBT / Share (Rs.), as of Mar 24, the value is 2.26. This value is within the healthy range. It has increased from 1.16 (Mar 23) to 2.26, marking an increase of 1.10.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 1.94. This value is below the healthy minimum of 2. It has increased from 0.78 (Mar 23) to 1.94, marking an increase of 1.16.
- For PBDIT Margin (%), as of Mar 24, the value is 16.92. This value is within the healthy range. It has increased from 16.29 (Mar 23) to 16.92, marking an increase of 0.63.
- For PBIT Margin (%), as of Mar 24, the value is 11.30. This value is within the healthy range. It has increased from 9.83 (Mar 23) to 11.30, marking an increase of 1.47.
- For PBT Margin (%), as of Mar 24, the value is 5.92. This value is below the healthy minimum of 10. It has increased from 3.76 (Mar 23) to 5.92, marking an increase of 2.16.
- For Net Profit Margin (%), as of Mar 24, the value is 5.08. This value is within the healthy range. It has increased from 2.55 (Mar 23) to 5.08, marking an increase of 2.53.
- For Return on Networth / Equity (%), as of Mar 24, the value is 8.36. This value is below the healthy minimum of 15. It has increased from 3.70 (Mar 23) to 8.36, marking an increase of 4.66.
- For Return on Capital Employeed (%), as of Mar 24, the value is 15.88. This value is within the healthy range. It has increased from 11.74 (Mar 23) to 15.88, marking an increase of 4.14.
- For Return On Assets (%), as of Mar 24, the value is 3.84. This value is below the healthy minimum of 5. It has increased from 1.68 (Mar 23) to 3.84, marking an increase of 2.16.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.15 (Mar 23) to 0.13, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.94. This value is within the healthy range. It has decreased from 0.96 (Mar 23) to 0.94, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.78. It has increased from 0.67 (Mar 23) to 0.78, marking an increase of 0.11.
- For Current Ratio (X), as of Mar 24, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.44 (Mar 23) to 1.48, marking an increase of 0.04.
- For Quick Ratio (X), as of Mar 24, the value is 0.76. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.76.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.32. This value is below the healthy minimum of 4. It has increased from 1.17 (Mar 23) to 1.32, marking an increase of 0.15.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 3.15. This value is within the healthy range. It has increased from 2.68 (Mar 23) to 3.15, marking an increase of 0.47.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.95. This value is below the healthy minimum of 3. It has increased from 1.42 (Mar 23) to 1.95, marking an increase of 0.53.
- For Enterprise Value (Cr.), as of Mar 24, the value is 360.05. It has increased from 144.83 (Mar 23) to 360.05, marking an increase of 215.22.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.57. This value exceeds the healthy maximum of 3. It has increased from 4.27 (Mar 23) to 8.57, marking an increase of 4.30.
- For EV / EBITDA (X), as of Mar 24, the value is 50.66. This value exceeds the healthy maximum of 15. It has increased from 26.22 (Mar 23) to 50.66, marking an increase of 24.44.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.04. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 8.04, marking an increase of 4.40.
- For Price / BV (X), as of Mar 24, the value is 13.23. This value exceeds the healthy maximum of 3. It has increased from 5.28 (Mar 23) to 13.23, marking an increase of 7.95.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.04. This value exceeds the healthy maximum of 3. It has increased from 3.64 (Mar 23) to 8.04, marking an increase of 4.40.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uravi T and Wedge Lamps Ltd:
- Net Profit Margin: 5.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.88% (Industry Average ROCE: 17.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.36% (Industry Average ROE: 22.11%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 268 (Industry average Stock P/E: 86.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.94
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.08%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Industry not found | Address not found | Contact not found |
FAQ
What is the latest intrinsic value of Uravi T and Wedge Lamps Ltd?
The latest intrinsic value of Uravi T and Wedge Lamps Ltd as on 30 January 2025 is ₹677.79, which is 64.51% higher than the current market price of ₹412.00, indicating the stock is undervalued by 64.51%. The stock has a market capitalization of 450 Cr. and recorded a high/low of 670/254 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹27.64 Cr and total liabilities of 69.28 Cr.
What is the Market Cap of Uravi T and Wedge Lamps Ltd?
The Market Cap of Uravi T and Wedge Lamps Ltd is 450 Cr..
What is the current Stock Price of Uravi T and Wedge Lamps Ltd as on 30 January 2025?
The current stock price of Uravi T and Wedge Lamps Ltd as on 30 January 2025 is 412.
What is the High / Low of Uravi T and Wedge Lamps Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Uravi T and Wedge Lamps Ltd stocks is 670/254.
What is the Stock P/E of Uravi T and Wedge Lamps Ltd?
The Stock P/E of Uravi T and Wedge Lamps Ltd is 268.
What is the Book Value of Uravi T and Wedge Lamps Ltd?
The Book Value of Uravi T and Wedge Lamps Ltd is 35.1.
What is the Dividend Yield of Uravi T and Wedge Lamps Ltd?
The Dividend Yield of Uravi T and Wedge Lamps Ltd is 0.00 %.
What is the ROCE of Uravi T and Wedge Lamps Ltd?
The ROCE of Uravi T and Wedge Lamps Ltd is 10.2 %.
What is the ROE of Uravi T and Wedge Lamps Ltd?
The ROE of Uravi T and Wedge Lamps Ltd is 8.83 %.
What is the Face Value of Uravi T and Wedge Lamps Ltd?
The Face Value of Uravi T and Wedge Lamps Ltd is 10.0.